TULARIK

tularik-logo

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell signaling and the control of gene expression. The company is focused primarily of three main areas; inflammation, metabolic diseases and oncology. Tularik was founded by David Goeddel along with Steve McKnight and Robert Tjian in 1991. The company was acquired by Amgen for US$ 1.3 billion in 2004.

#SimilarOrganizations #People #Financial #Website #More

TULARIK

Industry:
Biopharma Biotechnology Genetics Health Care Pharmaceutical

Founded:
1991-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.tularik.com

Total Employee:
251+

Status:
Active


Similar Organizations

fedora-pharmaceuticals-logo

Fedora Pharmaceuticals

Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.

morria-biopharmaceuticals-logo

Morria Biopharmaceuticals

Morria Biopharmaceuticals engages in the discovery and development of multi-functional anti-inflammatory drugs.

okairos-logo

Okairos

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

pairnomix-logo

Pairnomix

Pairnomix empowers physicians and patients who want to know more about rare genetic mutations and drugs that could be prescribed today.


Current Advisors List

frederick-dotzler_image

Frederick Dotzler Investor @ Tularik
Board_member

Current Employees Featured

steven-mcknight_image

Steven McKnight
Steven McKnight Co-Founder, Director of Research @ Tularik
Co-Founder, Director of Research

yasunori-kaneko_image

Yasunori Kaneko
Yasunori Kaneko Business Executive @ Tularik
Business Executive

Founder


david-goeddel_image

David Goeddel

steven-mcknight_image

Steven McKnight

Stock Details


Company's stock symbol is NASDAQ:TLRK

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Funding Round - Tularik

Official Site Inspections

http://www.tularik.com

  • Host name: users287.vip.heteml.jp
  • IP address: 157.7.189.147
  • Location: Tokyo Japan
  • Latitude: 35.6882
  • Longitude: 139.7532
  • Timezone: Asia/Tokyo
  • Postal: 102-0082

Loading ...

More informations about "Tularik"

Tularik - Crunchbase Company Profile & Funding

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell โ€ฆSee details»

Tularik Company Profile 2024: Valuation, Investors, โ€ฆ

Tularik General Information Description. Operator of a drug discovery and development company based in South San Francisco, California. The company specializes in research programs that include cancer, cytomegalovirus, โ€ฆSee details»

Tularik, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Nov 1, 2024 Explore Tularik, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 9 news, and 133 literature, Drug:T-900607, Batabulin Sodium, T-157602, โ€ฆSee details»

Amgen Completes Acquisition of Tularik; Acquisition Enhances โ€ฆ

"We welcome the Tularik staff into our organization and are confident that our combined research capacity will help patients by advancing important treatments for serious diseases." Pursuant โ€ฆSee details»

Tularik - Company Profile - Tracxn

Dec 9, 2024 Tularik - Drugs for cancer, inflammation, and immune disorders. Acquired by Amgen. Raised a total funding of $60M over 2 rounds from 1 investor. Tularik has 2867 โ€ฆSee details»

Amgen to Acquire Tularik for $1.3 Billion

Tularik's value at $25 per share based on the average Amgen stock price during a set number of trading days prior to the close of the transaction. The ... "David Goeddel has built a great โ€ฆSee details»

Tularik Inc. | Intellectual Property & Industry Research Alliances

Tularik, Inc. engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The companyโ€™s drugs include T67, T607, T131, โ€ฆSee details»

Tularik - Products, Competitors, Financials, Employees, โ€ฆ

Tularik's headquarters is located at 1120 Veterans Boulevard, South San Francisco. What is Tularik's latest funding round? Tularik's latest funding round is Acq - P2P. How much did โ€ฆSee details»

Part of Total Rewards - Amgen Inc.

โ€ข Like Tularik, Amgen also grants stock options widely throughout the organization. After the merger date, Amgen will grant 2004 stock options under its program to all Tularik employees โ€ฆSee details»

Tularik, Inc.:Company Profile & Technical Research,Competitor โ€ฆ

Tularik, Inc. is headquartered in United States California. Tularik, Inc. was founded in 1991. Tularik, Inc. has a total of 522 patents . Related Topics. Regulation of gene expression โ€ฆSee details»

Tularik - M&A Summary, Ownership, and Business Overview

Tularik currently has five drug candidates in clinical trials. In the cancer area, Tularik is currently conducting a pivotal study of T67 for the treatment of hepatocellular carcinoma and Phase 2 โ€ฆSee details»

Tularik - Funding, Financials, Valuation & Investors - Crunchbase

Jan 1, 1991 Tularik has raised 1 round. This was a Undisclosed round raised on Jan 1, 1991. Tularik is registered under the ticker NASDAQ:TLRK . Their stock opened with $14.00 in its โ€ฆSee details»

Tularik - LinkedIn

Tularik | 89 followers on LinkedIn. ... Novo Ventures Venture Capital and Private Equity Principals Birmingham, United Kingdom, West MidlandsSee details»

tularik.com Company Profile | Management and Employees List

Find contact information for tularik.com. Learn about their Manufacturing, Pharmaceuticals market share, competitors, and tularik.com's email format.See details»

Tularik - Contacts, Employees, Board Members, Advisors & Alumni

Tularik has 2 current employee profiles, including Co-Founder, Director of Research Steven McKnight. Tularik has 1 board member or advisor, Frederick Dotzler . ContactsSee details»

Tularik - Updates, News, Events, Signals & Triggers - Crunchbase

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. Search Crunchbase. Start Free Trial . Chrome Extension. โ€ฆSee details»

Tularik INC Reviews | Read Client Reviews of Tularik INC.

Read reviews of Tularik INC. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Search. โ€ฆSee details»

Tularik - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Dec 8, 2024 Tularik is actively using 13 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and SPF. UNLOCK PREMIUM โ€ฆSee details»

Tularik - Crunchbase

Companies like Tularik include Caladan Bio, Okairos, and Fedora Pharmaceuticals. Fedora Pharmaceuticals . Edmonton, Alberta, Canada 1-10 employees . Biopharma . Biotechnology . โ€ฆSee details»

linkstock.net © 2022. All rights reserved